Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iHuman (IH) Long-Term Investments (2021 - 2025)

iHuman has reported Long-Term Investments over the past 5 years, most recently at $3.7 million for Q4 2025.

  • Quarterly Long-Term Investments rose 1.28% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, up 1.28% year-over-year, with the annual reading at $3.8 million for FY2025, 4.38% up from the prior year.
  • Long-Term Investments was $3.7 million for Q4 2025 at iHuman, up from $3.7 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $15.6 million in Q4 2021 and troughed at $3.7 million in Q4 2023.
  • The 5-year median for Long-Term Investments is $3.7 million (2022), against an average of $6.1 million.
  • Biggest five-year swings in Long-Term Investments: crashed 76.25% in 2022 and later grew 1.28% in 2025.
  • Tracing IH's Long-Term Investments over 5 years: stood at $15.6 million in 2021, then crashed by 76.25% to $3.7 million in 2022, then dropped by 1.22% to $3.7 million in 2023, then increased by 0.24% to $3.7 million in 2024, then grew by 1.28% to $3.7 million in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $3.7 million, $3.7 million, and $3.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.